Opthamologist News


Welcome to the Opthamologist News page (Ophthalmologist News ).

This page is intended as a quick update on whats going on in the world of Opthamology, including ophthalmology studies, news and general articles. Have a browse and see if something catches your eye.

We have also added another  Opthalmology news page, that includes only the latest medical studies and results, so if you are an Opthamologist, then it is also worth a read: Ophthalmology Journal.

For our ‘General Eye Health’ news page, please see: Eye Health.

Enjoy reading.

Opthamologist News:

Could testosterone and/or estrogen play a future role in therapeutic strategies for dry eye?The British Journal of Ophthalmology (Source: Medscape Today Headlines)

MedWorm Message: Have you tried our new medical search engine? More powerful than before. Log on with your social media account. 100% free.

Posted: July 26, 2017, 3:14 am
(MedPage Today) -- Also, exercise, diet and other factors may regulate glaucoma (Source: MedPage Today Public Health)
Posted: July 26, 2017, 1:35 am
Patients value confirming and remembering next steps, quicker access and results, sharing information (Source: The Doctors Lounge - Psychiatry)
Posted: July 25, 2017, 11:00 pm
The tech giant and a leading US fusion company develop a new computer algorithm that significantly speeds up progress towards clean, limitless energyGoogle and a leading nuclear fusion company have developed a new computer algorithm which has significantly speeded up experiments on plasmas, the ultra-hot balls of gas at the heart of the energy technology.Tri Alpha Energy, which is backed by Microsoft co-founder Paul Allen, has raised over $500m ( £383m) in investment. It has worked with Google Research to create what they call the Optometrist algorithm. This enables high-powered computation to be combined with human judgement to find new and better solutions to complex problems.Continue reading... (Source: Guardian Unlimited Science)
Posted: July 25, 2017, 2:38 pm
Avalign Technologies announced that is has acquired Thortex and Millennium Surgical. The financial details of the deal were not disclosed. Thortex provides precision manufacturing, porous coatings and metal injection solutions to the medical device market. It has porous coating solutions for titanium and cobalt-chrome orthopedic implants and manufacturing and engineering technologies for medical device OEMs. Millennium Surgical offers specialty surgical instruments and more than 17,000 branded SKUs in a variety of clinical areas like neurosurgery, ophthalmics and orthopedics. Get the full story on our sister site, Medical Design & Outsourcing. The post Avalign Technologies acquires Thortex and Millennium Surgical appeared first on MassDevice. (Source: Mass Device)
Posted: July 25, 2017, 1:27 pm
The university moved to fire renowned ophthalmologist Carmen Puliafito days after a Los Angeles Times investigation revealed that videos showed repeated instances of him using illegal drugs.Medscape Medical News (Source: Medscape Medical News Headlines)

MedWorm Message: Have you tried our new medical search engine? More powerful than before. Log on with your social media account. 100% free.

Posted: July 24, 2017, 11:03 pm
Overall, 77 percent of physician specialties experienced increases in compensation (Source: Pulmonary Medicine News - Doctors Lounge)
Posted: July 24, 2017, 11:00 pm
BioLight Life Sciences (TLV:BOLT) touted data today from a Phase I/IIa clinical trial evaluating its Eye-D latanoprost insert. The device successfully lowered intraocular pressure during the study’s 12-week period and had a favorable safety profile, according to the Israel-based company. Get the full story at our sister site, Drug Delivery Business News. The post BioLight’s glaucoma insert succeeds in Phase I/IIa trial appeared first on MassDevice. (Source: Mass Device)
Posted: July 24, 2017, 6:33 pm
A 77-year-old woman's symptoms lead to a discovery of chronic optic disc elevation. What is the most likely cause?Medscape Ophthalmology (Source: Medscape Today Headlines)
Posted: July 24, 2017, 12:08 pm
Vernal keratoconjunctivitis, also known as spring catarrh, is a rare form of chronic eye allergy seen mostly in young children and teenagers.International Approvals (Source: Medscape Medical News Headlines)
Posted: July 24, 2017, 10:20 am
(MedPage Today) -- Artificial intelligence will bring'reality'to glaucoma diagnosis (Source: MedPage Today Ophthalmology)

MedWorm Message: Have you tried our new medical search engine? More powerful than before. Log on with your social media account. 100% free.

Posted: July 22, 2017, 1:35 pm
Aerie Pharmaceuticals (NSDQ:AERI) touted 12-month safety data yesterday from the Phase III registration trial of its Roclatan eye drops for intraocular pressure resulting from glaucoma or ocular hypertension. The study was designed to support Aerie’s new drug application submission to the FDA for Roclatan, which it expects to file in the first half of next year. Get the full story at our sister site, Drug Delivery Business News. The post Aerie touts late-stage safety data for Roclatan eye drops appeared first on MassDevice. (Source: Mass Device)
Posted: July 21, 2017, 7:14 pm
CONTACT lenses have vastly improved the options for those of poor sight. However, they can cause permanent vision loss if not worn properly. (Source: Daily Express - Health)
Posted: July 21, 2017, 7:01 pm
Investors in McLean-based VitalSpring Technologies Inc. received a bit of closure this week when they learned the health data company's former CEO and founder was sentenced to nearly 10 years in prison. Potomac ophthalmologist Dr. Sreedhar Potarazu received the sentence in federal court after pleading guilty to defrauding investors of $49 million and committing $7.5 million in employment tax fraud, Justice Department officials said. Potarazu, through an attorney, declined to comment. However, ot hers… (Source: bizjournals.com Health Care:Biotechnology headlines)
Posted: July 21, 2017, 6:10 pm
No significant increase in hand hygiene; stethoscope hygiene remained at zero after intervention (Source: The Doctors Lounge - Psychiatry)

MedWorm Message: Have you tried our new medical search engine? More powerful than before. Log on with your social media account. 100% free.

Posted: July 21, 2017, 4:00 pm
INTRODUCTION: Eye injury is the second most common cause of visual impairment and a leading cause of monocular blindness in the United States. There are approximately 6 million ED visits related to drug use annually, including misuse or abuse of pharmaceut... (Source: SafetyLit)
Posted: July 21, 2017, 12:05 pm
Title: Laser Therapy Shows Promise Against Eye 'Floaters'Category: Health NewsCreated: 7/20/2017 12:00:00 AMLast Editorial Review: 7/21/2017 12:00:00 AM (Source: MedicineNet Eyesight General)
Posted: July 21, 2017, 6:00 am
(Wayne State University - Office of the Vice President for Research) A team of Wayne State University researchers recently received a $1.9 million grant from the National Eye Institute of the National Institutes of Health to better understand leukodystrophies (LD) and genetic Leukoencephalopathies (gLE), rare genetic disorders affecting the white matter -- myelin -- in the central nervous system. Patients diagnosed with a leukodystrophy experience a gradual decline in development, including a progressive loss in gait, body tone, vision, hearing, swallowing and/or ability to eat. (Source: EurekAlert! - Biology)
Posted: July 21, 2017, 3:00 am
Kala Pharmaceuticals (NSDQ:KALA) today priced its initial public offering of 6 million shares of common stock at $15.00 apiece. The IPO is slated to bring in nearly $90 million for the Waltham, Mass.-based company. The offering, which is expected to close on July 25, includes a 30-day option for underwriters to buy up to 900,000 additional shares of common stock. Get the full story at our sister site, Drug Delivery Business News. The post Kala Pharmaceuticals prices $90m IPO appeared first on MassDevice. (Source: Mass Device)
Posted: July 20, 2017, 6:25 pm
These spots in vision can increase with age, researchers note Source: HealthDay Related MedlinePlus Pages: Eye Diseases, Vision Impairment and Blindness (Source: MedlinePlus Health News)

MedWorm Message: Have you tried our new medical search engine? More powerful than before. Log on with your social media account. 100% free.

Posted: July 20, 2017, 3:00 pm

-Please browse our other news pages, and find opthamologists and optometrists in your area. See the navigation.


Leave a Reply

Your email address will not be published. Required fields are marked *